All Research
    PAPER NLA-20Scientific Statement2024

    A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice

    2024 NLA focused update: measure Lp(a) at least once in adults; risk tiers of <75, 75-125 and >=125 nmol/L.

    Evidence

    —

    Not Rated

    Sample

    —

    subjects

    Duration

    —

    study period

    Journal

    Journal of Clinical Lipidology

    Mar 2024

    03

    Structured Methods

    Study Design
    Scientific Statement
    Sample Size
    Not reported
    Study Duration
    Not reported
    Methodology
    Not reported
    Limitations
    Not reported
    04

    Citations & References

    Cite this paper

    Unknown authors (2024). A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice. Journal of Clinical Lipidology.

    PubMed

    38565461

    Source

    Publisher

    Journal

    Journal of Clinical Lipidology

    05

    Indexing

    Biomarkers

    lp-a
    PHS
    671
    / 1000
    T3
    Longevity Operator

    Sample member

    Longevity Operator

    The Peak Human Score · PHS v1

    One number for your longevity journey.

    FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.

    • Metabolic
    • Hormonal
    • Cardiovascular
    • Brain / Cognitive
    • Sleep
    • Musculoskeletal
    • Gut
    • Immunity / Inflammation